Medicofarma Biotech SA (WSE:MDB)
0.4850
-0.0040 (-0.82%)
At close: Nov 21, 2025
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 32.97 million as of November 21, 2025. Its market cap has decreased by -8.83% in one year.
Market Cap
32.97M
Enterprise Value
32.95M
Revenue
281.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 32.97M, an increase of 407.22%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 32.97M | 25.00% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | 19.81M | 848.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.95B |
| NEUCA | 3.65B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.55B |
| Celon Pharma | 1.12B |
| Selvita | 826.00M |
| Centrum Medyczne ENEL-MED | 509.05M |
| Bioceltix | 451.57M |